Company: BDRX
Filing Date: 2025-05-12
Form Type: 424B3
Source: 0001214659-25-007340
Chunk: 12

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-12
Form: 424B3
Chunk 12
---
 available; |

| · | the success of any future acquisitions or other strategic transactions; |

| · | the difficulties of integrating the business of any future acquisitions into our own; |

| · | cybersecurity and other cyber incidents; |

| · | industry trends; |

| · | the impact of government laws and regulations; |

| · | regulatory, economic and political developments in the United Kingdom, the European Union, the United        
 States and other foreign countries, including any impact from the United Kingdom leaving the European Union; |

| · | the difficulties doing business internationally; |

| · | the ownership of our Ordinary Shares and Depositary Shares; |

| · | our ability to continue to meet the listing criteria required to remain listed on the NASDAQ Capital Market; |

| · | our ability to recruit or retain key scientific or management personnel or to retain our senior management; |

| · | the impact and costs and expenses of any litigation we may be subject to now or in the future; |

| · | the performance of third parties, including joint venture partners, our current sales force, our collaborators, 
 third-party suppliers and parties to our licensing agreements; and                                              |

| · | other risks and uncertainties, including those described in “Risk Factors” in this 
 prospectus.                                                                        |

Any forward-looking statements
that we make in this prospectus speak only as of the date of such statement, and we undertake no obligation to update such statements
to reflect events or circumstances after the date of this prospectus or to reflect the occurrence of unanticipated events. Comparisons
of results for current and any prior periods are not intended to express any future trends or indications of future performance, unless
expressed as such, and should only be viewed as historical data. You should, however, review the factors and risks we describe in the
reports we will file from time to time with the SEC after the date of this prospectus. See “Where You Can Find More Information.”

You should also read carefully
the factors described in “Risk Factors” in this prospectus, as well as elsewhere in this prospectus, to better understand
the risks and uncertainties inherent in our business and underlying any forward-looking statements. As a result of these factors, we cannot
assure you that the forward-looking statements in this prospectus will prove to be accurate. Furthermore, if our forward-looking statements
prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements,
you should not regard these statements as